Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1992 4
1993 4
1994 1
1995 4
1996 5
1997 4
1998 6
1999 9
2000 6
2001 10
2002 4
2003 17
2004 14
2005 11
2006 8
2007 19
2008 16
2009 5
2010 15
2011 16
2012 18
2013 25
2014 10
2015 19
2016 27
2017 24
2018 40
2019 43
2020 48
2021 49
2022 41
2023 47
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Results by year

Filters applied: . Clear all
Page 1
Scalp dysesthesia: a neuropathic phenomenon.
Ju T, Vander Does A, Yosipovitch G. Ju T, et al. Among authors: yosipovitch g. J Eur Acad Dermatol Venereol. 2022 Jun;36(6):790-796. doi: 10.1111/jdv.17985. Epub 2022 Feb 14. J Eur Acad Dermatol Venereol. 2022. PMID: 35122352 Review.
Transient Receptor Potential Channels and Itch.
Mahmoud O, Soares GB, Yosipovitch G. Mahmoud O, et al. Among authors: yosipovitch g. Int J Mol Sci. 2022 Dec 27;24(1):420. doi: 10.3390/ijms24010420. Int J Mol Sci. 2022. PMID: 36613861 Free PMC article. Review.
Immunotargets and Therapy for Prurigo Nodularis.
Labib A, Ju T, Vander Does A, Yosipovitch G. Labib A, et al. Among authors: yosipovitch g. Immunotargets Ther. 2022 Apr 26;11:11-21. doi: 10.2147/ITT.S316602. eCollection 2022. Immunotargets Ther. 2022. PMID: 35502157 Free PMC article. Review.
Skin changes in the obese patient.
Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Hirt PA, et al. Among authors: yosipovitch g. J Am Acad Dermatol. 2019 Nov;81(5):1037-1057. doi: 10.1016/j.jaad.2018.12.070. J Am Acad Dermatol. 2019. PMID: 31610857 Review.
Pruritus in Keloid Scars: Mechanisms and Treatments.
Hawash AA, Ingrasci G, Nouri K, Yosipovitch G. Hawash AA, et al. Among authors: yosipovitch g. Acta Derm Venereol. 2021 Oct 28;101(10):adv00582. doi: 10.2340/00015555-3923. Acta Derm Venereol. 2021. PMID: 34518894 Free PMC article. Review.
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials.
Yosipovitch G, Mollanazar N, Ständer S, Kwatra SG, Kim BS, Laws E, Mannent LP, Amin N, Akinlade B, Staudinger HW, Patel N, Yancopoulos GD, Weinreich DM, Wang S, Shi G, Bansal A, O'Malley JT. Yosipovitch G, et al. Nat Med. 2023 May;29(5):1180-1190. doi: 10.1038/s41591-023-02320-9. Epub 2023 May 4. Nat Med. 2023. PMID: 37142763 Free PMC article. Clinical Trial.
Itch: From mechanism to (novel) therapeutic approaches.
Yosipovitch G, Rosen JD, Hashimoto T. Yosipovitch G, et al. J Allergy Clin Immunol. 2018 Nov;142(5):1375-1390. doi: 10.1016/j.jaci.2018.09.005. J Allergy Clin Immunol. 2018. PMID: 30409247 Review.
Pruritus as a Distinctive Feature of Type 2 Inflammation.
Garcovich S, Maurelli M, Gisondi P, Peris K, Yosipovitch G, Girolomoni G. Garcovich S, et al. Among authors: yosipovitch g. Vaccines (Basel). 2021 Mar 23;9(3):303. doi: 10.3390/vaccines9030303. Vaccines (Basel). 2021. PMID: 33807098 Free PMC article. Review.
537 results